WallStreetZenWallStreetZen

NASDAQ: VTYX
Ventyx Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VTYX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$193.0M
Current Profit Margin
0%

VTYX Return on Equity

Current Company
-62.9%
Current Industry
-63.5%
Current Market
188%
VTYX's Return on Equity (-62.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VTYX announces earnings.

VTYX Return on Assets

Current Company
-57.7%
Current Industry
2.9%
VTYX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VTYX Return on Capital Employed

Current Company
-75.54%
Current Industry
19.5%
VTYX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VTYX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VTYX$0.00-$192.02M-$192.96MN/AN/A
ACRV$0.00-$59.07M-$60.39MN/AN/A
RENB$0.00-$40.26M-$41.23MN/AN/A
PSTX$64.70M-$109.04M-$123.43M+43.92%N/A
GALT$0.00-$41.86M-$44.81MN/AN/A
View Top Biotech Stocks

VTYX earnings dates

Next earnings date
Jun 5, 2024

Ventyx Biosciences Earnings & Revenue FAQ

What were VTYX's earnings last quarter?

On Invalid Date, Ventyx Biosciences (NASDAQ: VTYX) reported Q4 2023 earnings per share (EPS) of -$0.79, up 23.44% year over year. Total Ventyx Biosciences earnings for the quarter were -$46.75 million. In the same quarter last year, Ventyx Biosciences's earnings per share (EPS) was -$0.64.

If you're new to stock investing, here's how to buy Ventyx Biosciences stock.

What was VTYX's earnings growth in the past year?

As of Q2 2024, Ventyx Biosciences's earnings has grown year over year. Ventyx Biosciences's earnings in the past year totalled -$192.96 million.

What is VTYX's earnings date?

Ventyx Biosciences's earnings date is Invalid Date. Add VTYX to your watchlist to be reminded of VTYX's next earnings announcement.

What was VTYX's revenue last quarter?

On Invalid Date, Ventyx Biosciences (NASDAQ: VTYX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Ventyx Biosciences's revenue was $0.00.

What was VTYX's revenue growth in the past year?

As of Q2 2024, Ventyx Biosciences's revenue has grown null year over year. Ventyx Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.